Professor, University of Calgary

Dr. Suzanne Tough 's research on maternal health has led to fundamental changes in prenatal care, and clinical practice. She leads the innovative All Our Babies/Families study; a cohort of over 3000 families followed prospectively for 10 years resulting in a changed understanding of the relationship between early life events, mental health and long-term outcomes. She is a leader in translating evidence to practice, longitudinal research, and mental health. She is a Professor in the Cummings School of Medicine and has held leadership roles as a Scientific Director and Policy Fellow. She has ...


John Wallace has made important contributions to understanding the molecular mechanisms underlying the gastrointestinal ulcers and bleeding caused by aspirin and other nonsteroidal anti-inflammatory drugs. These are widely used drugs, particularly for treating arthritis, but their adverse effects are common and severe. Based on his mechanistic studies, he has designed and developed new hydrogen sulfide-releasing anti-inflammatory drugs that do not produce ulcers or bleeding, and is similarly working on novel drugs for the treatment of other inflammatory conditions, such as Crohn’s disease, ...


Distinguished ProfessorEmerita, University of Saskatchewan

One of Canada's leading nutrition scholars and an internationally recognized authority on vitamin D and calcium supplementation. For over 40 years, Dr. Whiting has conducted research on dietary influences of bone health, effectiveness of nutrient supplements and calcium and vitamin D status. She has served on internationally significant boards and panels such the Institute of Medicine's Committee on Use of Dietary Reference Intakes in Nutrition Labelling and the North American Dietary Supplements Advisory Board. She received the Canadian Nutrition Society Lifetime Achievement Award in 2012. ...


Stuart Peacock holds the Leslie Diamond Chair in Cancer Survivorship in the Faculty of Health Sciences at Simon Fraser University. He is Co-Director of the Canadian Centre for Applied Research in Cancer Control, and Head of the Department of Cancer Control Research at BC Cancer. He has over 200 publications, including papers in the BMJ, Journal of the American Medical Association, and Lancet Oncology. He has shaped healthcare priority setting in Canada, serves as a Board Director of the Canadian Agency for Drugs and Technologies in Health, and is an international advisor on cancer control ...


Clinical Scientist & Professor, University of Alberta

Dr. Brian H. Rowe, MD, MSc, CCFP(EM), FCCP, FCAHS Dr. Rowe is a clinician-scientist and professor in the Department of Emergency Medicine and the School of Public Health at the University of Alberta in Edmonton. He holds a Tier I Canada Research Chair (CRC) in Evidence-based Emergency Medicine (2011-2018) after a 10-year term as a Tier II CRC in Emergency Airway Diseases (2001-2011). He is the Scientific Director of the Institute of Circulatory and Respiratory Health (ICRH) at the Canadian Institutes of Health Research (CIHR).


Associate Dean and Director, McGill University

Professor Susan Rvachew, Ph.D., S-LP(C), ASHA Fellow, has received national and international recognition for outstanding professional achievements in the field of speech-language pathology practice and research. These achievements include theoretical and methodological advancements that highlight the role of speech perception in speech production development and speech disorders. She developed new computer-based assessment and treatment tools that have transformed speech therapy practice for the remediation of developmental speech sound disorders. She is well-known for her commitment to ...


Carol Richards is a Professor in the Department of Rehabilitation, Faculty of Medicine, Laval University and Director of the Centre for Interdisciplinary Research in Rehabilitation (CIRRIS). She was the founding Director (1994-2003) of the Quebec Provincial Rehabilitation Research Network and co-founder of the Canadian Consortium of Disability and Rehabilitation Research. She holds a Canada Research Chair in Rehabilitation and the Laval University Research Chair in Cerebral Palsy, and is a member of the Governing Council of CIHR. As one of the first physiotherapists in Canada to obtain a ...


Prof. School of Kinesiology & Health Studies, Queen's University

Dr. Robert Ross obtained a PhD in Exercise Physiology from the Université de Montréal in 1992. He is currently a Professor within the School of Kinesiology and Health Studies at Queen's University. His research program focuses on the development of strategies designed to manage lifestyle-based disease. He is a Past-President of the Canadian Society for Exercise Physiology, and Vice-President of the College of Kinesiology in Ontario. He is a Fellow of the American College of Sports Medicine, the American Heart Association, and is a recipient of the Honor Award from the Canadian Society of ...


Prof. Medicine, James McGill Chair & Medical Scientist, McGill University

Robyn Tamblyn has been an international leader in education. Following her PhD at McGill University, she continued her work at McGill on performance assessment but crucially began to analyze data about patient safety and public protection. Over two decades, she clarified the validity of medical licensing examinations; used health insurance data to clarify the reasons behind poor prescribing practices; and pioneered two integrated health data systems, IRIS-Quebec and Medical Office of the 21? Century (MOXXI), to improve prescribing practices and the quality and safety of health care for ...


Professor of Neuropharmacology, University of Prince Edward Island

Andrew Tasker is an internationally recognized neuroscientist. He has an extensive publication and presentation record and has acquired over $10 million in research funding. He also holds 6 patents issued or being prosecuted, has trained 16 postgraduate students, and has contributed significantly to both the Canadian Council on Animal Care and to community outreach activities. Dr. Tasker is best known for advancing our understanding of domoic acid (the “PEI mussel toxin”), the development of a neurodevelopmental rat model of epilepsy, and for his contributions within the Canadian Stroke ...